A decade of FDA-approved drugs (2010–2019): trends and future directions

DG Brown, HJ Wobst - Journal of medicinal chemistry, 2021 - ACS Publications
A total of 378 novel drugs and 27 biosimilars approved by the US Food and Drug
Administration (FDA) between 2010 and 2019 were evaluated according to approval …
被引用次数：202 相关文章

[引用][C] A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

DG Brown, HJ Wobst - Journal of Medicinal Chemistry, 2021 - cir.nii.ac.jp
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …

A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions.

DG Brown, HJ Wobst - Journal of Medicinal Chemistry, 2021 - europepmc.org
A total of 378 novel drugs and 27 biosimilars approved by the US Food and Drug
Administration (FDA) between 2010 and 2019 were evaluated according to approval …

A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions

DG Brown, HJ Wobst - Journal of medicinal chemistry, 2021 - pubmed.ncbi.nlm.nih.gov
A total of 378 novel drugs and 27 biosimilars approved by the US Food and Drug
Administration (FDA) between 2010 and 2019 were evaluated according to approval …